Stephen A. Berenson's most recent trade in Seres Therapeutics Inc was a trade of 11,470 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | Stephen A. Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 11,470 | 11,470 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Stephen A. Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |